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A b s t r a c t
Stroke, a vascular disease of the brain, is the #1 cause of disability and a major cause of death worldwide. Stroke has a major neg-
ative impact on the life of stroke-affected individuals, their families and the society. A significant proportion of stroke victims indicate 
that would have preferred death over their after-stroke quality of life. Mechanical thrombectomy (MT), opening the occluded artery 
using mechanical aspiration or a thrombus-entrapment device, is a guideline-mandated (class I, level of evidence A) treatment mo-
dality in patients with large vessel occlusion stroke. MT clinical benefit magnitude indicates that a universal access to this treatment 
strategy should be the standard of care. Today there is a substantial geographic variation in MT deliverability, with large-scale dispar-
ities in MT implementation. In many countries effective access to MT remains severely limited. In addition, many of the MT-treated 
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patients are treated too late for a good functional outcome because of logistic delays that include transportations to remotely located, 
scarce, comprehensive stroke centres. Position Paper from the European Society of Cardiology Council on Stroke and European Associ-
ation for Percutaneous Cardiovascular Interventions on interdisciplinary management of acute ischaemic stroke, developed with the 
support of the European Board of Neurointervention fills an important gap in systematically enabling interventional cardiologists to 
support stroke intervention in the geographic areas of unmet needs in particular. We review strengths and weaknesses of the docu-
ment, and suggest directions for the next steps that are swiftly needed to deliver MT to stroke patients more effectively.
Key words: acute ischaemic stroke, mechanical thrombectomy, cerebral resuscitation, unmet needs, cardiology cathlab-based 
treatment, multispecialty team.
translate into poorer clinical outcomes [10, 16]. Lack of 
physicians able to deliver MT in a timely fashion [1] and 
limiting MT procedures to the few sites with neuroradiol-
ogy facilities [17] have been identified as fundamental 
causes of inadequate MT delivery.
Interventional cardiologists already provide a fully op-
erational infrastructure with 24/7/365 service and large 
volume interventional service for patients with acute 
myocardial infarction and are highly skilled at reopening 
occluded arteries [18, 19] – something neurointervention-
ists rarely do outside of acute ischaemic stroke treatment 
[1], arguably making the cardiologist equally if not better 
suited to perform safe and effective MTs [1, 19]. Cardiol-
ogists who embark on providing MT are familiar with the 
differences between acute stroke and acute myocardial 
infarction, and they are well aware that cerebral arteries 
are not coronary arteries [20, 21]. They are also aware of 
the need for training in navigation through the cerebral 
vessels as well as stroke-specific and MT-specific training 
[20, 21]. 
A  long-awaited Position Paper from the European 
Society of Cardiology (ESC) Council on Stroke and the 
European Association for Percutaneous Cardiovascular 
Interventions on interdisciplinary management of acute 
ischaemic stroke, developed with the support of the Euro-
pean Board of Neurointervention (abbreviated below as 
ESC/EAPCI/EBNI Position Paper on interdisciplinary acute 
ischaemic stroke management) [22] fills an important 
gap in systematically enabling interventional cardiolo-
gists to support stroke intervention in the geographic ar-
eas of unmet needs [14, 15, 22] in particular. The present 
document [22] stems from an earlier ESC Position Paper 
devoted to larger aspects of cardiology participation in 
stroke primary and secondary prevention that have been 
an unquestionable part of this specialty training, and 
performance, over decades, now highlighting the need to 
strengthen the stroke neurology-cardiology crosstalk in 
post-stroke patient work-up [23, 24]. 
One significant strength of the present ESC Position 
Paper [22] is the European Board of Neurointervention 
(a co-developer of the document) recognition of the un-
met needs in MT deliverability resulting from the short-
age of MT centres and physicians in many geographic 
areas [22]. Equally important is the European Board of 
Neurointervention acknowledgement that trained cardi-
ologists “can” deliver MTs (“Interventional cardiologists 
Stroke, a vascular disease of the brain, is the number 
1 cause of disability and a major cause of death world-
wide [1, 2]. Stroke has a major negative impact on the life 
of stroke-affected individuals, their families and society 
[2]. With conservative stroke management, a significant 
proportion of stroke victims would have preferred death 
over their after-stroke quality of life [3]. Despite unques-
tionable progress in pharmacologic and non-pharmaco-
logic prevention, the burden of cardiovascular disease 
(including stroke) will not be decreasing – but increasing 
– over the next 25 years [4]. 
Mechanical thrombectomy (MT), opening the occlud-
ed artery using mechanical aspiration [5, 6] or a throm-
bus-entrapment device [6], is a  guideline-mandated 
(class I, level of evidence A) treatment modality in pa-
tients with large vessel occlusion stroke that constitutes 
at least 15% of ischaemic strokes [2] (note that several 
consecutive patient series show that this proportion may 
be significantly higher, reaching ~30–45% [1, 7]). MT, if 
administered timely, translates into at least a 2-fold in-
crease of the likelihood of a  good functional outcome 
(functional independence after stroke) [8, 9]. The mag-
nitude of the MT clinical benefit indicates that universal 
access to this treatment strategy should be the standard 
of care [2, 6]. The basis of MT clinical efficacy is its rapid 
delivery in a maximally achievable proximity to the dis-
ease onset place, as patient transportations for MT are 
associated with prolongation of ongoing cerebral tissue 
loss and worsened clinical outcomes [10–13]. 
Today, in Europe and worldwide, there is substan-
tial geographic variation in MT deliverability, with large 
scale disparities in MT implementation between neigh-
bouring countries [14, 15]. In many countries effective 
access to MT remains severely limited [14, 15]. In addi-
tion, many of the MT-treated patients are treated too 
late for a  good functional outcome because of logistic 
delays that include, in many cases, transportations to 
remotely located comprehensive stroke centres (CSCs, 
Level 1 stroke centres) [10–13]. Time to intervention is 
critical: patients revascularized ≤ 2 h achieve ~90% good 
functional neurological recovery, whereas the recovery 
associated with the commonly encountered delays of 
≥ 6 h is considerably less, yielding ~20% [8, 9]. Thus any 
healthcare system that mandates transporting patients 
to (scarce) CSCs rather than treating them (if feasible) 
locally [16] introduces unnecessary treatment delays that 
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adequately trained to perform endovascular stroke in-
terventions could complement stroke teams to provide 
the 24/7 on call duty and thus to increase timely access 
of stroke patients to endovascular treatment”) [22], con-
cluding the discussion on who “should” or “be allowed” 
to deliver MT [25–30]. The document rightly states that 
“training of interventional cardiologists to treat AIS pa-
tients using standard requirements will contribute to 
achieve broad access to endovascular stroke treatment, 
especially in regions and countries which are lacking this 
24/7 service” [22]. The need to continue establishing 
Level 2 centres (thrombectomy-capable stroke centres, 
treating ≥ 100 stroke patients per year and performing 
≥ 50 stroke thrombectomies per year) [22] is clearly, and 
rightly, voiced in the document – along with the need of 
travel for MT distance not exceeding (if feasible) 1 h and 
the need of at least 2 MT centres per million population, 
adequately distributed across the country [22]. The doc-
ument [22] rightly recognizes that there is no need for 
on-site neurosurgery in Thrombectomy-Capable Stroke 
Centres (Level 2 centres). Indeed, majority of centers 
in Mr CLEAN and other pivotal trials of MT [31] did not 
(and do not) have on-site neurosurgery. This terminates 
the misconception [32] of on-site neurosurgery “need” 
to deliver MT to stroke patients, in line with the recent 
American Heart Association/American Stroke Organi-
zation guidelines, which clearly indicate that stroke MT 
treatment should not be limited to neuroradiology-run 
Comprehensive Stroke Centres: “Regional systems of 
stroke care should be developed. These should consist of 
the following: (a) Healthcare facilities that provide initial 
emergency care, including administration of i.v. alteplase, 
and, (b) Centers capable of performing endovascular 
stroke treatment with comprehensive periprocedural care 
to which rapid transport can be arranged when appro-
priate (Class of recommendation I, Level of evidence A)”. 
One more important strength of the present ESC Council 
on Stroke/EAPCI/EBNI position paper [2] is that it lists 
fundamental quality assurance thresholds. These include 
(1) successful recanalisation (modified TICI 2b or 3) in at 
least 60% of cases, (2) embolization to new territory of < 
15%, and (3) symptomatic intra-cranial haemorrhage (i.e. 
parenchymal haematoma on imaging with clinical dete-
rioration) rate < 10%. Unfortunately, other quality assur-
ance thresholds directly linked to patient outcome, such 
as the time to device deployed, time to recanalization 
as well as pre-, peri- and postprocedural blood pressure 
management, are not presently considered [22]. Further-
more, the timeline to completed workup of underlying 
causes, specifically of cardiac and extracranial origins 
[23], is not listed [22].
An important step backwards in the current ESC/
EAPCI/EBNI position paper [23] is its drift away from pre-
vious positions [33], with the present inexplicable lack 
of recognition of operator experience in carotid artery 
stenting (CAS). Irrespective of the CAS experience of the 
operator, the ESC/EAPCI/EBNI document proposes an 
unrealistic training quota that includes the new need to 
perform a minimum of 50 MTs in training (at least 25 as 
first operator) [22]. Despite the title suggestion that the 
ESC/EAPCI/EBNI Position Paper on interdisciplinary acute 
ischaemic stroke management is based on “evidence” 
[22], no clinical (or other) evidence has been provided to 
support these unrealistic numbers. On the other hand, 
there is the real-life evolution of cathlab cardiology ser-
vices that safely and effectively add MT to their routine 
high-volume CAS service in order to address the urgent 
need for this life-saving treatment [24, 34–38]. Indeed, 
one in five acute ischaemic stroke patients have a proxi-
mal internal carotid or vertebrobasilar artery pathology in 
mechanistic relation to stroke [22]. Obviously, if an opera-
tor already has experience in CAS, they are experienced in 
navigating the most challenging supra-aortic vessels (in-
cluding balloon catheter use) and do not need to (re-)train 
these skills in order to perform MT [1, 18, 19, 24, 34, 38]. 
A  prior position clearly recognized experience in carot-
id stenting (≥ 25 procedures as first operator) and listed 
10 acute stroke thrombectomies as sufficient credential-
ing [33]. If the present document requirements, including 
the need to perform 50 MTs in order to be able to start 
delivering MTs as part of a Thrombectomy-Capable Stroke 
Centre service [22], were introduced in a  country that 
does not have an adequate number of physicians per-
forming MT, the recommendation of 50 MT procedures 
will be prohibitive to expand the service. Consequently, 
this number must be seen as unrealistic. This ESC/EAP-
CI/EBNI direction also strongly contrasts with the North 
American approach. The US Joint Commission statement 
(2019) [39] suspended the USA operator training and 
volume requirement as they recognized them to be un-
realistic, given the need to urgently expand MT services. 
Similarly, no minimum number of MTs within the training 
requirements is listed in the recent Training Guidelines 
for Endovascular Ischemic Stroke Intervention Multi-So-
ciety Consensus Document [40].
Poland is a country where the shortage of MT cen-
tres and operators results in severe under-treatment of 
the Polish MT stroke population [17, 28–30]. The MT 
rate in 2020 was as low as ~3.1%, compared to 7.5–
8.1% in the neighbouring Czech Republic and Germany 
(both systems have cardiologist participation [34, 37, 
41]). With a  population of 38 million, this difference 
translates to at least 2500 disabilities that could have 
been – but were not – prevented over the last 3 years 
[17]. This estimate does not take into consideration 
further disabilities resulting from MT delays due to pa-
tient transportation [10–13, 16] (about 0.5 thrombec-
tomy-capable centres per one million population in Po-
land [40], in contrast to the recommended two centres 
per million [22]). 
It is clear that procedure-related patient safety can-
not be compromised. However, it is also obvious that pa-
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tients who can be treated locally with MT should not be 
transported to another centre [19, 24, 42], losing their 
MT benefit (brain) on the way [8, 9, 13]. 
MT equals cerebral resuscitation [17]. Large-vessel 
occlusion causes (focal) brain ischaemia [2]. This is in 
many ways analogous to global brain ischaemia as a re-
sult of cardiac arrest. There is no doubt among specialists 
and lay people that, in case of a cardiac arrest, cardio-pul-
monary resuscitation is needed as quickly as possible. 
No one in this scenario would suggest referring patients 
(with arrested blood flow to the brain) to sparse regional 
resuscitation centres of excellence [17].
As a model solution for a developing system, follow-
ing multispecialty consultations, Thrombectomy-Capable 
Stroke Centres and noninterventional radiologist opera-
tor requirements have been recently agreed on and set in 
Poland as a Minister of Health Ordinance [42]. Require-
ments for interventionalists who are not neuroradiolo-
gists include, among other training, participation in at 
least 150 carotid or intracranial artery interventions with 
50 procedures as the first operator (5 of which are intra-
cranial, proctorship accepted). The need to enhance MT 
deliverability was recently echoed by the 2021 position 
paper on stroke thrombectomy by the Chamber of Physi-
cians (Poland) [43]. It states that having proven skills and 
practical experience of performing MT is what matters 
– not the medical specialty. The document [43] further 
states that, as a life-saving and disability-preventing pro-
cedure, MTs performed in Thrombectomy-Capable Stroke 
Centres should be reimbursed to the hospitals by the 
National Health Fund, similarly to reimbursement to the 
Comprehensive Stroke Centres listed by the Minister of 
Health [43].
In contrast to elective procedures, MT is a procedure 
that cannot be “arranged” for training in a desired time 
and location. Operator experience in CAS en route to MT 
should be recognized and result in a  shorter pathway 
to becoming certified in MT [19, 33]. In light of recent 
evidence showing no excess complications in MTs per-
formed by cardiologists (and those with CAS experience 
in particular) [34–37]) the presently suggested unrealis-
tic “first operator” MT delivery requirements including 
50 prior MTs [22] should be replaced or suspended.
Further evolution of the ESC/EAPCI/EBNI Position Pa-
per on interdisciplinary acute ischaemic stroke manage-
ment [22] should take into consideration the regional 
needs and variations, with the Polish accreditation sys-
tem allowing for combined CAS and MT cases in opera-
tor credentialing [42] serving as a potential model. While 
“hands-on” experience in treating real-life patients with 
MT remains fundamentally necessary, operator require-
ments should include other forms of training that are al-
ready effective in other areas of interventional medicine. 
These include supervised simulator and cadaveric mod-
el training with varying clinical and anatomic scenarios 
and complications [44, 45] as well as remote proctorship 
and multispecialty team training [46, 47]. Implementa-
tion of visual decision-aiding tools [48] and MT outcome 
prediction models [49] should also be included. Strict 
quality assurance remains a  must to ensure patient 
safety [22, 42]. 
All in all, while the present document offers some im-
portant contributions, the next steps are urgently needed 
to deliver MT to stroke patients more effectively [50]. 
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